Cargando…
Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia
IMPORTANCE: Atypical antipsychotics (AAPs) are often used off-label to manage dementia-associated neuropsychiatric symptoms. In 2005, the US Food and Drug Administration (FDA) issued a boxed warning for the use of AAPs in elderly patients. The long-term association of this warning with health outcom...
Autores principales: | Rubino, Annalisa, Sanon, Myrlene, Ganz, Michael L., Simpson, Alex, Fenton, Miriam C., Verma, Sumit, Hartry, Ann, Baker, Ross A., Duffy, Ruth A., Gwin, Keva, Fillit, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189225/ https://www.ncbi.nlm.nih.gov/pubmed/32343351 http://dx.doi.org/10.1001/jamanetworkopen.2020.3630 |
Ejemplares similares
-
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2020) -
Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2019) -
Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019) -
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
por: Halpern, Rachel, et al.
Publicado: (2018) -
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
por: Bent-Ennakhil, Nawal, et al.
Publicado: (2017)